Martin Dow
Martin Dow Group is a privately held Pakistani pharmaceutical company that manufactures, markets, imports, and exports generic prescription and over-the-counter medicines, serving healthcare providers and patients through national distribution networks across Pakistan.
- Company typePrivate
- Founded1995
- HeadquartersKarachi, Pakistan
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Martin Dow does
Martin Dow Group is a privately held, Pakistan-domiciled generic pharmaceutical company founded in 1995 and headquartered in Karachi. It manufactures, markets, imports, and exports pharmaceutical products including prescription medicines and over-the-counter drugs, and is described as Pakistan's fifth-largest pharmaceutical group. The company operates a 1,001-5,000 employee base and serves healthcare providers and patients through traditional pharmaceutical distribution channels — wholesalers, distributors, and direct hospital and pharmacy sales — within a primarily domestic footprint across South Asia.
The company's product and technology stack combines legacy generics manufacturing with an emerging digital layer. In 2025, Martin Dow Group hosted its first Tech Day to publicly launch data-driven healthcare initiatives in partnership with SAP and Salesforce, integrating AI, machine learning for anomaly detection, IoT systems for automated production, and predictive analytics across research, supply chain management, and regulatory processes. Specific individual product names were not disclosed in available sources. The company also pursues sustainability initiatives, receiving the OICCI Climate Excellence Awards 2026 for renewable energy integration and conservation practices.
Martin Dow monetizes through physical product sales of generic pharmaceuticals across prescription and retail channels, with pricing managed through standard negotiated channels rather than publicly disclosed pricing. Revenue mechanics are volume-driven, dependent on the Pakistan healthcare market and broader South Asian demand. The company is privately held with no public ticker or disclosed funding rounds; no revenue figure is publicly available. Ownership structure, parent entities, and detailed financial history are not disclosed in available sources, representing material data gaps for investors.
Martin Dow firmographics
Firmographics- Name
- Martin Dow
- Legal name
- Martin Dow Group
- Website
- https://martindow.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Martin Dow Group is a privately held Pakistani pharmaceutical company that manufactures, markets, imports, and exports generic prescription and over-the-counter medicines, serving healthcare providers and patients through national distribution networks across Pakistan.
- Ownership category
- akta.pro rank
Martin Dow industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)
Keywords
Where Martin Dow is headquartered
LocationHeadquarters
- HQ city
- Karachi
- HQ country
- Pakistan
- HQ region
- Asia
Offices1 record
Markets served
Martin Dow business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Products: Martin Dow Group operates as Pakistan's fifth-largest pharmaceutical group, manufacturing and distributing pharmaceutical products including prescription medicines and over-the-counter drugs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Martin Dow product offering
Product offeringCore offering
Martin Dow manufactures, markets, imports, and exports generic pharmaceutical products, including prescription medicines and over-the-counter drugs, operating as Pakistan's fifth-largest pharmaceutical group. The company distributes these products through traditional pharmaceutical channels within Pakistan and is integrating AI, machine learning, IoT, and predictive analytics into its research, supply chain, and regulatory operations.
Product overview
Martin Dow Group is Pakistan's fifth-largest pharmaceutical group offering pharmaceutical products and healthcare solutions. The company is undergoing digital transformation, hosting its first Tech Day in 2025 to advance data-driven healthcare through partnerships with SAP and Salesforce. No specific individual product names were identified in the available sources.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Sustainability recognition through OICCI Climate Excellence Awards 2026 for renewable energy integration
Companies that use Martin Dow
Customer profileSegments1 record
Ideal customer profiles1 record
Martin Dow technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature4 records
Martin Dow partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- SAPcoreSAP partnership for data-driven healthcare initiatives in Pakistan. Martin Dow Group launched initiatives with SAP as part of its first Tech Day event to advance digital transformation in pharmaceutical operations and healthcare delivery.
- SalesforcecoreSalesforce partnership for data-driven healthcare initiatives in Pakistan. Martin Dow Group launched initiatives with Salesforce as part of its first Tech Day event to advance data-driven healthcare and customer relationship management in the pharmaceutical sector.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Martin Dow competitors and assessment
Company assessmentDirect peers
- The Searle Company: Listed Pakistani pharmaceutical group manufacturing and marketing generics and branded pharma; competes head-to-head with Martin Dow in the domestic generics market with similar product breadth.
- PharmEvo: Pakistan-based pharmaceutical company manufacturing and marketing branded generics; comparable mid-tier Pakistani peer competing in overlapping therapeutic segments.
- Bosch Pharmaceuticals: Pakistani pharma manufacturer and exporter of generic formulations; directly competes with Martin Dow in domestic manufacturing, distribution and export channels.
- Getz Pharma: Pakistan-headquartered generic pharmaceutical manufacturer with broad domestic and export operations; directly comparable to Martin Dow in scale, generics focus, and Pakistan-centric distribution.
- Sami Pharmaceuticals: Pakistan-based pharmaceutical manufacturer with branded generics and specialty product lines; comparable in domestic focus and product portfolio breadth.
- Hilton Pharma: Karachi-based pharmaceutical manufacturer focused on generics and specialty products; close peer in size, therapeutic mix, and Pakistan-centric GTM.
Broad incumbents
- Sanofi Pakistan: Pakistan subsidiary of Sanofi, offering branded specialty and generics; broader portfolio than Martin Dow but competes in overlapping therapeutic areas.
- Abbott Laboratories Pakistan: Subsidiary of global pharma major Abbott; broad incumbent operating across branded and generics in Pakistan, competing with Martin Dow across multiple therapeutic categories.
- GlaxoSmithKline Pakistan: Local arm of GSK with a wide branded pharma, vaccines and consumer-health portfolio; competes with Martin Dow particularly in OTC and prescription categories.
Emerging players
- Cipla: Indian-headquartered global generics manufacturer with significant export reach; a key cross-border competitor shaping pricing dynamics for Martin Dow in Pakistan and emerging markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Martin Dow social profiles
Digital presenceMartin Dow financial estimates
Financial estimateRevenue estimate
Valuation estimate
Martin Dow leadership team
Management profileNumber of profiles
Martin Dow funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Martin Dow M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Martin Dow
What does Martin Dow do?
Martin Dow manufactures, markets, imports, and exports generic pharmaceutical products, including prescription medicines and over-the-counter drugs, operating as Pakistan's fifth-largest pharmaceutical group. The company distributes these products through traditional pharmaceutical channels within Pakistan and is integrating AI, machine learning, IoT, and predictive analytics into its research, supply chain, and regulatory operations.
Is Martin Dow a public or private company?
Martin Dow is a private company. It is classified as unknown and is currently operating.
When was Martin Dow founded?
Martin Dow was founded in 1995. It employs 1,001 to 5,000 people.
Where is Martin Dow based?
Martin Dow is headquartered in Karachi, Pakistan, in the Asia region.
How does Martin Dow make money?
One revenue line is on record: pharmaceutical Products.
Who are Martin Dow's main competitors?
Direct peers on record are The Searle Company, PharmEvo, Bosch Pharmaceuticals, Getz Pharma, Sami Pharmaceuticals and Hilton Pharma. Broad incumbents are Sanofi Pakistan, Abbott Laboratories Pakistan and GlaxoSmithKline Pakistan. Cipla is listed as an emerging player.
Does Martin Dow have an API?
No public API is recorded for Martin Dow.
What industry is Martin Dow in?
Martin Dow's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 32541 and its SIC code is 2834.